Article Versions Notes

Sabit H, Abouelnour S, Hassen BM, Magdy S, Yasser A, Wadan A-HS, Abdel-Ghany S, Radwan F, Alqosaibi AI, Hafiz H, et al. Anticancer Potential of Prebiotics: Targeting Estrogen Receptors and PI3K/AKT/mTOR in Breast Cancer. Biomedicines. 2025; 13(4):990. https://doi.org/10.3390/biomedicines13040990

Sabit, Hussein, Sama Abouelnour, Bassel M. Hassen, Salma Magdy, Ahmed Yasser, Al-Hassan Soliman Wadan, Shaimaa Abdel-Ghany, Faisal Radwan, Amany I. Alqosaibi, Hala Hafiz, and et al. 2025. "Anticancer Potential of Prebiotics: Targeting Estrogen Receptors and PI3K/AKT/mTOR in Breast Cancer" Biomedicines 13, no. 4: 990. https://doi.org/10.3390/biomedicines13040990

Sabit, H., Abouelnour, S., Hassen, B. M., Magdy, S., Yasser, A., Wadan, A.-H. S., Abdel-Ghany, S., Radwan, F., Alqosaibi, A. I., Hafiz, H., Awlya, O. F. A., & Arneth, B. (2025). Anticancer Potential of Prebiotics: Targeting Estrogen Receptors and PI3K/AKT/mTOR in Breast Cancer. Biomedicines, 13(4), 990. https://doi.org/10.3390/biomedicines13040990